MicroRNA 1233-2 (MIR1233-2)

MicroRNA 1233-2 (MIR1233-2) is a short, non-coding RNA molecule classified as a microRNA (miRNA) and encoded in the human genome[1]. Like other miRNAs, it consists of ~20–24 nucleotides and regulates gene expression at the post-transcriptional level, mainly by binding to target mRNAs and causing translational inhibition or mRNA degradation[1][2][4]. MicroRNAs are transcribed by RNA polymerase II as part of primary transcripts (pri-miRNAs), processed by Drosha and Dicer RNases to yield a mature form that is loaded into the RNA-induced silencing complex (RISC)[1][2][4]. MIR1233-2 itself is not classified as a protein or conventional drug target (such as a receptor, enzyme, ion channel, or transporter) and is mainly annotated in genomic databases rather than pharmacological literature[1]. There are no documented drug interactions, disease associations, or biomarker applications specific to this microRNA as of current knowledge.

Other names

hsa-mir-1233-2MIR1233-2